Researchers from the Kirby Institute say its time to remove restrictions that prevent recent drug users from accessing successful hepatitis C treatment.
A report from the UNSW Centre for Social Research in Health says stigma and language are still barriers to treatment.
Newly released data from the Kirby Institute show a decline in the uptake of life-saving treatments among people living with hepatitis C.
New research from NDARC and the Kirby Institute at UNSW Sydney shows almost 40% of people who have injected drugs in the past year are living with hepatitis C.
Proposed changes to Victoria's drug laws and policies have potential but fall short in some key areas.
Research to improve the lives of drug users and investigate high rates of falls in Aboriginal and Torres Strait Islander people are the biggest UNSW winners in the final round of 2017 NHMRC funding.
Reviews of the global prevalence of injecting drug use and of interventions to prevent the spread of blood-borne viruses among people who inject drugs paint a worrying picture.
As new treatments for hepatitis C reshape the landscape, new data from UNSW underscore the need to address issues including discrimination, stigma and engaging marginalised communities.
Tens of thousands of Australians have been cured of Hepatitis C since March 2016, writes Greg Dore.
Research from The Kirby Institute released for World Hepatitis Day shows Australia could be one of the first countries in the world to eliminate hepatitis C.